Skip to main content

Facioscapulohumeral Muscular Dystrophy clinical trials at UC Irvine

1 in progress, 0 open to eligible people

Showing trials for
  • Del-brax (Also Referred to as AOC 1020) in Participants With FSHD

    Sorry, not currently recruiting here

    A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous AOC 1020 for the Treatment of Facioscapulohumeral Muscular Dystrophy (FSHD)

    Orange, California and other locations

Last updated: